ClinicalTrials.gg
Not yet recruitingNCT06827028HOPEUpdated Apr 27, 2025

Global Survey on Newborns' HOspitalisation and Parental Experiences - the HOPE Study

An observational study in Infant, Premature, Infant, Low Birth Weight and Parents, sponsored by Global Foundation for the Care of Newborn Infants. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-27.

Sponsored by Global Foundation for the Care of Newborn Infants · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 68 studies in Premature Birth with a site in Germany — 11 open to participants now, 13 under way, 1 of them phase 3. Premature Birth · Germany.

Planned enrollment
19th of 28
100 · median 225
Started
2025
with 3 others
Observational
28 of 68
7 open now
Primary completion
2026-03
later than 5 of 12 live
Registered
63rd of 68
by date
Lead sponsor
2 of 68
Global Foundation for the Care of Newborn Infants

Among the 68 studies in Premature Birth with a site in Germany, this one is the 19th largest by planned enrollment of the 28 observational ones that give a count, is one of 4 that started in 2025, is one of 28 observational ones, reaches primary completion later than 5 of the 12 other live ones, and was the 63rd registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

11 of the 68 studies in Premature Birth with a site in Germany are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 68 studies in Premature Birth with a site in Germany, or all of them as a file.
02

Study summary

This study aims to explore parents' experiences and emotional burdens related to their newborn's hospital stay using an online survey. Our target population consists of parents of newborns born preterm, with low birthweight, or critically ill. Particularly the presence of infant- and family-centred developmental care (IFCDC) principles as well as support through political framework conditions will be investigated.

Read the detailed description

Collaboration partners, expert working groups and their roles This project will be carried out in close collaboration with representatives of national parent organisations and professional healthcare societies. The following societies are involved as collaboration partners: ANA (African Neonatal Association), CNN (Canadian Neonatal Network), COINN (Council of International Neonatal Nurses), ESPR (European Society for Paediatric Research), NFI (NIDCAP Federation International), UENPS (Union of European Neonatal and Perinatal Societies), WHO Collaborating Centre for Maternal and Child Health. All collaboration partners delegate one representative that supports the Core Working Group (CWG).

The CWG, with n=27 members, and a Support Group (SG), with n=48 members, both consisting of individual multi-professional experts from all continents working in the field of maternal and newborn health, will be assembled. Both groups support the development of the questionnaire in a two-step approach, translations of the questionnaire, the recruitment of participants, data analysis, data interpretation, and publication and dissemination of results. While the CWG, will be actively involved in the initial development of the draft questionnaire, the SG will be involved for a broader review for the revision and final correction of the questionnaire in a second step.

Development of the Questionnaire For the purpose of the HOPE study, we performed a scoping review (1) to explore the available literature related to this topic and to identify the most relevant topics to be included in the questionnaire.

After this literature research, the questionnaire was drafted considering the already existing and validated EMPATHIC-N and the PICKER questionnaires (2,3), as well as the questionnaire, we previously developed to explore parents' experiences related to challenges during the COVID-19 pandemic regarding the care of their newborns (4,5). In addition, questions related to political, social and infrastructural framework conditions were included.

The online questionnaire includes single, multiple choice answer models and some open-text fields. Besides questions related to participant characteristics such as age, sex, country of location, infant birthweight, duration of hospitalisation, etc., the questionnaire includes questions related to the parents' perception of political, social and infrastructural framework conditions as experienced within their country as well as elements of neonatal care mainly involving aspects of IFCDC such as the use and support of breast/human milk and early breast feeding, skin-to-skin care (kangaroo-mother care), parental presence and involvement in the care, shared decision making, stress and pain control etc. during their hospital stay.

In order to maximise the reach and to prevent the loss of study participants due to time constraints, a multi-stage approach will be used, beginning with 47 high-priority questions (single and multiple answer options), followed by more specific second lower-priority questions (single and multiple answer options) (n=21). This first/second layer approach aims to increase the response rate for the most important questions and to keep the effort for participants with limited time resources to a minimum, while taking advantage of the motivation of participants who are willing to share the full scope of their experiences related to their baby's hospitalisation.

The questionnaire draft will be reviewed by the CGW and after having implemented necessary changes, the updated version will be shared with the larger SG for feedback and review. Both groups will ensure that the questionnaire considers the specific national perspective and that the questions are phrased. All implemented changes and the finally updated version of the questionnaire will be discussed with both groups including the representative from the collaboration partners in digital discussion meetings.

In addition, comprehensive interviews with up to 10 participants resembling the target group will be performed to elucidate other relevant topics that may have not yet been covered and need to be included.

The first questionnaire draft (in English) with included feedback from the interviews and experts and will be pre-tested by a comparable target group to receive qualitative feedback on the questionnaire per se and the phrasing.

After a potential adaptation based on data and information of the pre-testing, the questionnaire will be translated in as many different languages as feasible to overcome the linguistic barrier and facilitate participation for parents worldwide. The CWG and SG will support and review the translations. The translated questionnaire versions will be transferred into the online survey software SurveyMonkey ® and will be distributed via the expert groups, GFCNI's network, GFCNI's newsletter and social media channels via an access link.

03

Conditions studied

  • Infant, Premature
  • Infant, Low Birth Weight
  • Parents
  • Life Change Events
  • Needs Assessment
  • Anxiety
  • Fear
  • Stress, Psychological
  • Uncertainty
  • Emotions
  • Caregiver Burden

Keywords

  • Parental needs
  • Infant- and Family-centred developmental care
  • IFCDC
  • EFCNI
  • NICU
  • Global Parent Survey
  • Breastfeeding
  • Breastfeeding support
  • Politics
  • Needs Assessment
  • HRQoL
  • Parents
  • Infant, Newborn
  • Family
  • Family Support
  • Family Health
  • Intensive Care, Neonatal
  • Patient-Centered Care
  • Infant Care
  • Surveys and Questionnaires
  • Health Care Surveys
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Parent or caregiver of a newborn infant born on January 1, 2023, or thereafter, who received/is receiving special/intensive care starting within the first week of life such as oxygen therapy or other respiratory support, incubator treatment, intravenous infusions, treatment of (suspected) sepsis, pneumonia, necrotising enterocolitis, malformations, jaundice, nutritional/feeding problems, hypoglycemia, etc.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Parent or caregiver of a newborn infant born on January 1, 2023, or thereafter, who received/is receiving special/intensive care starting within the first week of life such as oxygen therapy or other respiratory support, incubator treatment, intravenous infusions, treatment of (suspected) sepsis, pneumonia, necrotising enterocolitis, malformations, jaundice, nutritional/feeding problems, hypoglycemia, etc.

Exclusion criteria

Exclusion Criteria:

  • Other family members than parents/(primary) caregivers
  • Parents of newborns that did not receive special/intensive care starting within the first week of life
  • Parents or caregivers of infants born before 1 January 2023
  • Persons with insufficient proficiency of one of the languages of the questionnaire
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Parents/participants

    Study participants are parents of newborns that are receiving or received special/intensive care starting within the first week of life and that are born on 1 January 2023 or thereafter. The cohort consists of persons with different ethnic background in different countries that voluntarily participate in the survey.

    Other: N/A, no intervention, participation in survey

Interventions

  • OtherN/A, no intervention, participation in survey

    N/A, no intervention, participation in survey

06

What researchers measure

Primary outcomes

  1. Infant Family-Centered Developmental Care principles

    The implementation of IFCDC principles will be measured as the percentage of infants receiving specific care, such as skin-to-skin contact, receiving breastfeeding support, access of parents/caregivers to the neonate, involvement in daily care procedures etc.

    Time frame: 01/09/2025 - 31/12/2027

Secondary outcomes

  1. Social/Financial/Political Support (Quantitative)

    This section will include approximately 10 questions assessing quantitative data on support received by the mother/parents, such as support to access of care, financial compensation for additional expenses (transportation to the hospital, reimbursement for sleeping facilities), social/political support, such as maternity leave etc. The final outcome still depends on the expert decision.

    Time frame: 01/09/2025 - 31/12/2027

  2. Social/Financial/Political Support (Qualitative)

    Subjective qualitative data on support received by the mother/parents, such as support to access of care, financial compensation for additional expenses, social/political support, such as maternity leave etc. indicated by participants via open text fields.

    Time frame: 01/09/2025 - 31/12/2027

  3. Participant characteristics

    Data on Participant characteristics will be collected (such as marital status, parental education etc., and infant characteristics to analyse the influence of these data on the availability of care according the IFCDC principles and describe the study sample.

    Time frame: 01/09/2025 - 31/12/2027

  4. Questionnaire pre-testing (quantitative)

    Quantitative evaluation data of the pre-testing of the questionnaire related to the understandability of questions, utilisation of lay language, appropriateness of selected questions.

    Time frame: 01/09/2025 - 31/12/2027

  5. Questionnaire pre-testing (qualitative)

    Qualitative evaluation data of the pre-testing of the questionnaire indicated in open text fields.

    Time frame: 01/09/2025 - 31/12/2027

Other outcomes

  1. Single-Country evaluation of IFCDC implementation

    The level IFCDC implementation will be analysed per country. Inter-country comparison will be performed to derive recommendations for action.

    Time frame: 01/09/2025 - 31/12/2027

  2. Single-Country evaluation on the availability of supportive political measures

    The availability of supportive political measures will be analysed per country. Inter-country comparison will be performed to derive recommendations for action.

    Time frame: 01/09/2025 - 31/12/2027

07

Study locations

1 site
  • Global Foundation for the Care of Newborn Infants (GFCNI)
    Munich, Bavaria 81379, Germany
    • Julia Hoffmann, Dr · ContactJulia.hoffmann@gfcni.org · +49 89 89 0 83 260
    • Christina Tischer, Dr · Contactchristina.tischer@gfcni.org
    • Luc Zimmermann, Professor · Principal investigator
    • Julia Hoffmann, Dr · Sub investigator
    • Christina Tischer, Dr · Sub investigator
    • Helmut Hummler, M.D., M.B.A. · Sub investigator
    • Silke Mader · Sub investigator
08

References and documents

Publications

  • Kostenzer J, Hoffmann J, von Rosenstiel-Pulver C, Walsh A, Zimmermann LJI, Mader S; COVID-19 Zero Separation Collaborative Group. Neonatal care during the COVID-19 pandemic - a global survey of parents' experiences regarding infant and family-centred developmental care. EClinicalMedicine. 2021 Aug 6;39:101056. doi: 10.1016/j.eclinm.2021.101056. eCollection 2021 Sep. PubMed 34401688 ↗
  • Kostenzer J, von Rosenstiel-Pulver C, Hoffmann J, Walsh A, Mader S, Zimmermann LJI; COVID-19 Zero Separation Collaborative Group. Parents' experiences regarding neonatal care during the COVID-19 pandemic: country-specific findings of a multinational survey. BMJ Open. 2022 Apr 7;12(4):e056856. doi: 10.1136/bmjopen-2021-056856. PubMed 35393317 ↗
  • Sakonidou S, Kotzamanis S, Tallett A, Poots AJ, Modi N, Bell D, Gale C. Parents' Experiences of Communication in Neonatal Care (PEC): a neonatal survey refined for real-time parent feedback. Arch Dis Child Fetal Neonatal Ed. 2023 Jul;108(4):416-420. doi: 10.1136/archdischild-2022-324548. Epub 2023 Jan 30. PubMed 36717224 ↗
  • Gill FJ, Wilson S, Aydon L, Leslie GD, Latour JM. Empowering Parents of Australian Infants and Children in Hospital: Translation, Cultural Adaptation, and Validation of the EMpowerment of PArents in The Intensive Care-30-AUS Questionnaire. Pediatr Crit Care Med. 2017 Nov;18(11):e506-e513. doi: 10.1097/PCC.0000000000001309. PubMed 28906423 ↗
  • Family-centered care in the NICU in a global setting : Ayse Duezenli : Free Download, Borrow, and Streaming. Available from: https://archive.org/details/osf-registrations-erqf7-v1

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2025; primary completion for Mar 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2024
First posted
Feb 14, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Mar 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Apr 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06827028
Lead sponsor
Global Foundation for the Care of Newborn Infants
Responsible party
Luc Zimmermann (Professor, Global Foundation for the Care of Newborn Infants) — Principal investigator
First posted
Feb 14, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Mar 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Apr 27, 2025

Study contacts

Julia Hoffmann, Dr
Contact
julia.hoffmann@gfcni.org
+49 89 89 0 83 260
Christina Tischer, Dr
Contact
christina.tischer@gfcni.org
Silke Mader
study chair · Global Foundation for the Care of Newborn Health (GFCNI)
Helmut Hummler, M.D., M.B.A.
study director · Global Foundation for the Care of Newborn Health (GFCNI)
Luc Zimmermann, Professor
principal investigator · Global Foundation for the Care of Newborn Health (GFCNI)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion